An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201.
about
Impact of New Genomic Technologies on Understanding Adverse Drug ReactionsProgress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicityClozapine-induced blood dyscrasias in Saudi Arab patients.Applications of pharmacogenetics in psychiatry: personalisation of treatment.Non-chemotherapy drug-induced agranulocytosis.The promise and reality of pharmacogenetics in psychiatryPharmacogenetics of antipsychotics: recent progress and methodological issues.Clozapine-induced agranulocytosis and its genetic determinants.Clinically available pharmacogenomics testsPharmacogenetic considerations in the treatment of psychiatric disorders.Genetics of antipsychotic-induced side effects and agranulocytosis.Pharmacogenetics of response to antipsychotics in patients with schizophrenia.Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia.Pharmacogenetics in schizophrenia: a review of clozapine studies.Individualizing clozapine and risperidone treatment for schizophrenia patients.More than 25 years of genetic studies of clozapine-induced agranulocytosis.Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
P2860
Q26787099-EC685792-76D4-4A0D-8E26-485DF5E148F2Q28083100-57E61DCC-9FEA-4EFF-86B5-AB9ED7637B34Q33415861-6AB70594-8E5A-4444-AAB2-FBDF82654C02Q34240923-308B09BA-CD00-4C6A-918B-640C40407E46Q34579237-F162F1C1-6C2E-4A01-A1C8-ED540BC6ABD5Q35226451-FC8778D6-783C-4DFE-A27B-76E55CD24E02Q36539833-F2D8452F-6EB6-4F23-A23D-4A8E89E256A3Q37235641-CA8F016C-1301-4EDD-91D2-F3C90A0EA9CEQ37314487-2DB7538A-57D7-4329-9BC2-DA7F975EBE1EQ37681573-516709AB-E7C3-4BAC-A7D1-17D9E6090DF4Q37845227-E8F10B86-F23C-4C46-BC1F-A8E80D6E97E0Q37952823-E4E99F2A-E054-439E-BC51-48A4A557D6CEQ37960512-A68D6264-5A1F-42B2-85E2-513F6FF60855Q38154175-1A693779-C8A3-4839-BEB2-A337E98041CCQ38170458-C8A42A5A-E350-40CF-B4F3-442CDA9BC8CEQ39247893-94041191-B1C8-4858-8056-8DAB1FB586F2Q57491589-FA55AE97-A9F2-42C3-9F8B-98A75775DDE2
P2860
An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
An association between clozapi ...... izophrenics and HLA-DQB1*0201.
@ast
An association between clozapi ...... izophrenics and HLA-DQB1*0201.
@en
type
label
An association between clozapi ...... izophrenics and HLA-DQB1*0201.
@ast
An association between clozapi ...... izophrenics and HLA-DQB1*0201.
@en
prefLabel
An association between clozapi ...... izophrenics and HLA-DQB1*0201.
@ast
An association between clozapi ...... izophrenics and HLA-DQB1*0201.
@en
P2093
P1476
An association between clozapi ...... izophrenics and HLA-DQB1*0201.
@en
P2093
Avraham Amar
Bernard Lerer
Chaim Brautbar
Cilly Safirman
Leny Sherman
Ronnen H. Segman
Shlomo Shtrussberg
P356
10.1017/S1461145798001023
P577
1998-07-01T00:00:00Z